Development of array based comparative genomic hybridization (CGH) as a diagnostic tool for cryptic chromosome aberrations in congenital disorders

开发基于阵列的比较基因组杂交(CGH)作为先天性疾病中隐性染色体畸变的诊断工具

基本信息

  • 批准号:
    17390099
  • 负责人:
  • 金额:
    $ 9.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

The human genome sequencing project had been conducted successfully, with 99% of the genome sequenced with 99.99% accuracy. In the post-sequence era, detection of disease-related genomic alterations is directly connected with identification of genes associated with multiple congenital anomalies with mental retardation (MCA/MR), autism, and other unknown genomic disorders. However, we had none of tools for exploring cryptic chromosome aberrations at 100kb-level. In order to overcome the situation, we have constructed high-resolution CGH-arrays as follows, (1) Whole Genome Array (WGA)-4500, which contains 4523 BACs throughout the whole genome, (2) Cancer Array-800, which harbors 800 BACs for different cancer-related genes, (3) 1p36-contig array, which covers about 20Mb spanning 1p36 region with 212 BACs, (4) Chromosome X-tiling array, which contains 1001 BACs throughout chromosome X except pseudo-autosomal region, and (5) Genome Disorder (GD)-array, which is employed as the diagnostic tool for known genomic disorders. Using those in-house BAC arrays, we explored cryptic chromosome aberrations in a large number of patients with MCA/MR, and detected de novo submicroscopic aberrations related to the pathogenesis of unknown MCA/MR in some of those patients.
人类基因组测序计划已经成功实施,99%的基因组测序准确率达到99.99%。在后测序时代,疾病相关基因组改变的检测与鉴定与多种先天性异常伴精神发育迟滞(MCA/MR)、自闭症和其他未知基因组疾病相关的基因直接相关。然而,我们没有任何工具来探索100 kb水平的隐性染色体畸变。为了克服这种情况,我们构建了如下高分辨率CGH阵列:(1)全基因组阵列(WGA)-4500,其包含贯穿整个基因组的4523个BAC,(2)癌症阵列-800,其包含不同癌症相关基因的800个BAC,(3)1 p36-contig阵列,其覆盖约20 Mb跨越1 p36区域,具有212个BAC,(4)染色体X-平铺阵列,其包含除了假常染色体区域之外的整个染色体X的1001个BAC,和(5)基因组病症(GD)-阵列,其用作已知基因组病症的诊断工具。使用这些内部BAC阵列,我们探讨了大量MCA/MR患者的隐性染色体畸变,并在其中一些患者中检测到与未知MCA/MR发病机制相关的从头亚显微畸变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dup(8p)/del(8q) recombinant chromosome in a girl with hepatic focal nodular hyperplasia
Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    K. Nishioka;Shin Hayashi;M. Farrer;A. Singleton;H. Yoshino;H. Imai;Toshiaki Kitami;Kenichi Sato;R. Kuroda;H. Tomiyama;K. Mizoguchi;M. Murata;T. Toda;I. Imoto;J. Inazawa;Y. Mizuno;N. Hattori
  • 通讯作者:
    K. Nishioka;Shin Hayashi;M. Farrer;A. Singleton;H. Yoshino;H. Imai;Toshiaki Kitami;Kenichi Sato;R. Kuroda;H. Tomiyama;K. Mizoguchi;M. Murata;T. Toda;I. Imoto;J. Inazawa;Y. Mizuno;N. Hattori
Clinical and molecular cytogenetic characterization od two patients with non-mutational aberrations of the FMR2 gene.
两名 FMR2 基因非突变畸变患者的临床和分子细胞遗传学特征。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Honda S;Inazawa J;et al.
  • 通讯作者:
    et al.
食道癌の検出方法
如何发现食道癌
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
癌の検出方法および抑制方法
如何检测和控制癌症
  • DOI:
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

INAZAWA Johji其他文献

INAZAWA Johji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('INAZAWA Johji', 18)}}的其他基金

Innovative development of DDS for microRNA therapeutics by an application of anti-PCSK9 antibody
应用抗 PCSK9 抗体创新开发用于 microRNA 疗法的 DDS
  • 批准号:
    16K14630
  • 财政年份:
    2016
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Chromothripsis-like pattern in cancer-cell genome after irradiation by a focused vertical micro-beam system, SPICE
聚焦垂直微束系统 SPICE 照射后,癌细胞基因组中出现类似染色体碎裂的模式
  • 批准号:
    25640062
  • 财政年份:
    2013
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of diagnostic tools for personalized cancer medicine by genomic and epigenomic analyses
通过基因组和表观基因组分析开发个性化癌症医学诊断工具
  • 批准号:
    22240090
  • 财政年份:
    2010
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Integrative genomics and epigenomics for personalized cancer medicine
个性化癌症医学的综合基因组学和表观基因组学
  • 批准号:
    17015012
  • 财政年份:
    2005
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Establishment of array-based CGH technology and its use for-diagnosis of genetic diseases in clinical setting
基于芯片的CGH技术的建立及其在临床遗传疾病诊断中的应用
  • 批准号:
    15390112
  • 财政年份:
    2003
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Exploring novel cancer-related genes within novel amplifications detected by CGH in gastrointestinal tumors
在胃肠道肿瘤中 CGH 检测到的新扩增中探索新的癌症相关基因
  • 批准号:
    13470252
  • 财政年份:
    2001
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Cytogenetics and molecular genetics of malignant gliomas
恶性胶质瘤的细胞遗传学和分子遗传学
  • 批准号:
    01480360
  • 财政年份:
    1989
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Identification of Loci and Genes for Autosomal Recessive Mental Retardation and Autism in Consanguineous Pakistani Families
巴基斯坦近亲家庭常染色体隐性智力低下和自闭症位点和基因的鉴定
  • 批准号:
    188912
  • 财政年份:
    2009
  • 资助金额:
    $ 9.34万
  • 项目类别:
    Operating Grants
Neuroligin Function in vivo: Implications for Autism and Mental Retardation
Neuroligin 体内功能:对自闭症和智力迟钝的影响
  • 批准号:
    7996583
  • 财政年份:
    2008
  • 资助金额:
    $ 9.34万
  • 项目类别:
Neuroligin Function in vivo: Implications for Autism and Mental Retardation
Neuroligin 体内功能:对自闭症和智力迟钝的影响
  • 批准号:
    8196923
  • 财政年份:
    2008
  • 资助金额:
    $ 9.34万
  • 项目类别:
Neuroligin Function in vivo: Implications for Autism and Mental Retardation
Neuroligin 体内功能:对自闭症和智力迟钝的影响
  • 批准号:
    7573138
  • 财政年份:
    2008
  • 资助金额:
    $ 9.34万
  • 项目类别:
Neuroligin Function in vivo: Implications for Autism and Mental Retardation
Neuroligin 体内功能:对自闭症和智力迟钝的影响
  • 批准号:
    7752578
  • 财政年份:
    2008
  • 资助金额:
    $ 9.34万
  • 项目类别:
Neuroligin Function in vivo: Implications for Autism and Mental Retardation
Neuroligin 体内功能:对自闭症和智力迟钝的影响
  • 批准号:
    8389578
  • 财政年份:
    2008
  • 资助金额:
    $ 9.34万
  • 项目类别:
MRI SCANNER: AUTISM, MENTAL RETARDATION, MEMORY, BRAIN RADIATION IN CHILDREN
MRI 扫描仪:儿童自闭症、智力低下、记忆力、脑辐射
  • 批准号:
    7335117
  • 财政年份:
    2006
  • 资助金额:
    $ 9.34万
  • 项目类别:
Treating Self-Abuse in Autism and Mental Retardation
治疗自闭症和智力低下的自虐
  • 批准号:
    6603570
  • 财政年份:
    2002
  • 资助金额:
    $ 9.34万
  • 项目类别:
Treating Self-Abuse in Autism and Mental Retardation
治疗自闭症和智力低下的自虐
  • 批准号:
    6485783
  • 财政年份:
    2002
  • 资助金额:
    $ 9.34万
  • 项目类别:
TREATING SELF-ABUSE IN AUTISM AND MENTAL RETARDATION
治疗自闭症和智力低下的自虐行为
  • 批准号:
    2776073
  • 财政年份:
    2000
  • 资助金额:
    $ 9.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了